605 related articles for article (PubMed ID: 29793736)
1. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
Rojewski AM; Tanner NT; Dai L; Ravenel JG; Gebregziabher M; Silvestri GA; Toll BA
Chest; 2018 Jul; 154(1):110-118. PubMed ID: 29793736
[TBL] [Abstract][Full Text] [Related]
2. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening.
Tanner NT; Thomas NA; Ward R; Rojewski A; Gebregziabher M; Toll BA; Silvestri GA
Chest; 2020 Nov; 158(5):2184-2191. PubMed ID: 32603713
[TBL] [Abstract][Full Text] [Related]
3. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
4. Nicotine dependence as an independent risk factor for atherosclerosis in the National Lung Screening Trial.
Zhu J; Nelson K; Toth J; Muscat JE
BMC Public Health; 2019 Jan; 19(1):103. PubMed ID: 30669994
[TBL] [Abstract][Full Text] [Related]
5. Time to first cigarette predicts cessation outcomes in adolescent smokers.
Mercincavage M; Branstetter SA; Muscat JE; Horn KA
Nicotine Tob Res; 2013 Dec; 15(12):1996-2004. PubMed ID: 23811009
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial.
Thomas NA; Ward R; Tanner NT; Rojewski AM; Toll B; Gebregziabher M; Silvestri GA
Chest; 2023 Feb; 163(2):433-443. PubMed ID: 36162480
[TBL] [Abstract][Full Text] [Related]
7. Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.
Fucito LM; Czabafy S; Hendricks PS; Kotsen C; Richardson D; Toll BA;
Cancer; 2016 Apr; 122(8):1150-9. PubMed ID: 26916412
[TBL] [Abstract][Full Text] [Related]
8. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
[TBL] [Abstract][Full Text] [Related]
9. A combined smoking cessation intervention within a lung cancer screening trial: a pilot observational study.
Pozzi P; Munarini E; Bravi F; Rossi M; La Vecchia C; Boffi R; Pastorino U
Tumori; 2015; 101(3):306-11. PubMed ID: 25838249
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.
Kumar P; Gareen IF; Lathan C; Sicks JD; Perez GK; Hyland KA; Park ER
Oncologist; 2016 Jan; 21(1):40-9. PubMed ID: 26712960
[TBL] [Abstract][Full Text] [Related]
11. Time to smoke first morning cigarette and lung cancer in a case-control study.
Gu F; Wacholder S; Kovalchik S; Panagiotou OA; Reyes-Guzman C; Freedman ND; De Matteis S; Consonni D; Bertazzi PA; Bergen AW; Landi MT; Caporaso NE
J Natl Cancer Inst; 2014 Jun; 106(6):dju118. PubMed ID: 24948709
[TBL] [Abstract][Full Text] [Related]
12. Perception of Lung Cancer Risk: Impact of Smoking Status and Nicotine Dependence.
Greillier L; Cortot AB; Viguier J; Brignoli-Guibaudet L; Lhomel C; Eisinger F; Morère JF; Couraud S
Curr Oncol Rep; 2018 Mar; 20(Suppl 1):18. PubMed ID: 29508085
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
14. The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers.
Schnoll RA; Goren A; Annunziata K; Suaya JA
Addiction; 2013 Nov; 108(11):1989-2000. PubMed ID: 23795712
[TBL] [Abstract][Full Text] [Related]
15. Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial.
Guertin KA; Gu F; Wacholder S; Freedman ND; Panagiotou OA; Reyes-Guzman C; Caporaso NE
PLoS One; 2015; 10(5):e0125973. PubMed ID: 25985429
[TBL] [Abstract][Full Text] [Related]
16. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
[TBL] [Abstract][Full Text] [Related]
17. A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
Ferketich AK; Otterson GA; King M; Hall N; Browning KK; Wewers ME
Lung Cancer; 2012 May; 76(2):211-5. PubMed ID: 22088938
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.
Taylor KL; Williams RM; Li T; Luta G; Smith L; Davis KM; Stanton CA; Niaura R; Abrams D; Lobo T; Mandelblatt J; Jayasekera J; Meza R; Jeon J; Cao P; Anderson ED;
J Natl Cancer Inst; 2022 Oct; 114(10):1410-1419. PubMed ID: 35818122
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
20. Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening.
Gu F; Cheung LC; Freedman ND; Katki HA; Caporaso NE
J Thorac Oncol; 2017 Nov; 12(11):1646-1653. PubMed ID: 28818607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
